

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sensory perception of smell (GO:0007608) | 9.45707639 |
| 2 | cerebellar Purkinje cell layer development (GO:0021680) | 7.50332058 |
| 3 | fructose metabolic process (GO:0006000) | 7.04171960 |
| 4 | protein heterotetramerization (GO:0051290) | 6.80258025 |
| 5 | C4-dicarboxylate transport (GO:0015740) | 6.58026975 |
| 6 | metanephric tubule development (GO:0072170) | 6.33628292 |
| 7 | metanephric nephron tubule development (GO:0072234) | 6.33628292 |
| 8 | collecting duct development (GO:0072044) | 6.01172356 |
| 9 | protein insertion into membrane (GO:0051205) | 5.96338041 |
| 10 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 5.95366877 |
| 11 | cellular sodium ion homeostasis (GO:0006883) | 5.94864249 |
| 12 | neurofilament cytoskeleton organization (GO:0060052) | 5.89164897 |
| 13 | protein localization to cilium (GO:0061512) | 5.89097344 |
| 14 | metanephric nephron epithelium development (GO:0072243) | 5.86060796 |
| 15 | * sensory perception of chemical stimulus (GO:0007606) | 5.74170693 |
| 16 | detection of calcium ion (GO:0005513) | 5.59626826 |
| 17 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 5.54323804 |
| 18 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 5.39342300 |
| 19 | metanephric epithelium development (GO:0072207) | 5.37373626 |
| 20 | musculoskeletal movement (GO:0050881) | 5.35980977 |
| 21 | multicellular organismal movement (GO:0050879) | 5.35980977 |
| 22 | inositol phosphate-mediated signaling (GO:0048016) | 5.30261024 |
| 23 | positive regulation of muscle hypertrophy (GO:0014742) | 5.27846970 |
| 24 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 5.27846970 |
| 25 | aggressive behavior (GO:0002118) | 5.27765532 |
| 26 | retina layer formation (GO:0010842) | 5.11596311 |
| 27 | synaptic vesicle exocytosis (GO:0016079) | 4.96128038 |
| 28 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.81922599 |
| 29 | neuron cell-cell adhesion (GO:0007158) | 4.73251665 |
| 30 | relaxation of smooth muscle (GO:0044557) | 4.72895181 |
| 31 | behavioral response to nicotine (GO:0035095) | 4.71654026 |
| 32 | positive regulation of synapse maturation (GO:0090129) | 4.65151253 |
| 33 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.62926274 |
| 34 | cellular potassium ion homeostasis (GO:0030007) | 4.57261370 |
| 35 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.55453038 |
| 36 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.53436060 |
| 37 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.42813650 |
| 38 | glutamate secretion (GO:0014047) | 4.38817076 |
| 39 | behavioral response to cocaine (GO:0048148) | 4.38797686 |
| 40 | response to pheromone (GO:0019236) | 4.37178799 |
| 41 | glutamate receptor signaling pathway (GO:0007215) | 4.24046810 |
| 42 | cerebellar granule cell differentiation (GO:0021707) | 4.22473371 |
| 43 | positive regulation of glomerulus development (GO:0090193) | 4.22335140 |
| 44 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.19730931 |
| 45 | retinal cone cell development (GO:0046549) | 4.15640673 |
| 46 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.13074717 |
| 47 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 4.08871298 |
| 48 | negative regulation of norepinephrine secretion (GO:0010700) | 4.00367265 |
| 49 | vocalization behavior (GO:0071625) | 3.97494645 |
| 50 | long term synaptic depression (GO:0060292) | 3.97175040 |
| 51 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.96614585 |
| 52 | negative regulation of heart rate (GO:0010459) | 3.95332199 |
| 53 | phosphorelay signal transduction system (GO:0000160) | 3.94770742 |
| 54 | regulation of cilium movement (GO:0003352) | 3.93978739 |
| 55 | neuronal action potential propagation (GO:0019227) | 3.93610892 |
| 56 | mating behavior (GO:0007617) | 3.93019745 |
| 57 | relaxation of cardiac muscle (GO:0055119) | 3.85802503 |
| 58 | positive regulation of amino acid transport (GO:0051957) | 3.84911156 |
| 59 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.84222113 |
| 60 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.81861768 |
| 61 | auditory receptor cell stereocilium organization (GO:0060088) | 3.81717719 |
| 62 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.80652629 |
| 63 | negative regulation of fatty acid transport (GO:2000192) | 3.80587260 |
| 64 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.80383748 |
| 65 | innervation (GO:0060384) | 3.79777116 |
| 66 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.73645766 |
| 67 | nephron tubule development (GO:0072080) | 3.71606641 |
| 68 | regulation of potassium ion transmembrane transport (GO:1901379) | 3.68273548 |
| 69 | transmission of nerve impulse (GO:0019226) | 3.68201308 |
| 70 | response to water (GO:0009415) | 3.67783560 |
| 71 | regulation of synapse maturation (GO:0090128) | 3.64075045 |
| 72 | protein localization to synapse (GO:0035418) | 3.62719343 |
| 73 | relaxation of muscle (GO:0090075) | 3.60721295 |
| 74 | synaptic vesicle endocytosis (GO:0048488) | 3.59574582 |
| 75 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.59371654 |
| 76 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.58615562 |
| 77 | regulation of synaptic vesicle transport (GO:1902803) | 3.57632101 |
| 78 | synaptic vesicle maturation (GO:0016188) | 3.56882441 |
| 79 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.53345212 |
| 80 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.52672266 |
| 81 | potassium ion homeostasis (GO:0055075) | 3.52507119 |
| 82 | detection of light stimulus involved in visual perception (GO:0050908) | 3.51767075 |
| 83 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.51767075 |
| 84 | neuron-neuron synaptic transmission (GO:0007270) | 3.51022636 |
| 85 | neurotransmitter secretion (GO:0007269) | 3.51007115 |
| 86 | cell differentiation in hindbrain (GO:0021533) | 3.50267036 |
| 87 | dopamine biosynthetic process (GO:0042416) | 3.49902021 |
| 88 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.49711216 |
| 89 | intraciliary transport (GO:0042073) | 3.46757726 |
| 90 | layer formation in cerebral cortex (GO:0021819) | 3.46653480 |
| 91 | synaptic transmission, glutamatergic (GO:0035249) | 3.46565889 |
| 92 | axonal fasciculation (GO:0007413) | 3.44989834 |
| 93 | serotonin metabolic process (GO:0042428) | 3.44965416 |
| 94 | parturition (GO:0007567) | 3.44242155 |
| 95 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.40250067 |
| 96 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.37568496 |
| 97 | potassium ion transmembrane transport (GO:0071805) | 3.37256280 |
| 98 | cellular potassium ion transport (GO:0071804) | 3.37256280 |
| 99 | response to ammonium ion (GO:0060359) | 3.35708290 |
| 100 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.35501949 |
| 101 | neuron recognition (GO:0008038) | 3.34350779 |
| 102 | cGMP metabolic process (GO:0046068) | 3.34208177 |
| 103 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.34175999 |
| 104 | axoneme assembly (GO:0035082) | 3.33666160 |
| 105 | regulation of neurotransmitter secretion (GO:0046928) | 3.32267956 |
| 106 | acidic amino acid transport (GO:0015800) | 3.31501151 |
| 107 | regulation of dopamine secretion (GO:0014059) | 3.28243924 |
| 108 | sodium ion homeostasis (GO:0055078) | 3.28023519 |
| 109 | renal tubule development (GO:0061326) | 3.27030053 |
| 110 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.26896491 |
| 111 | membrane depolarization during action potential (GO:0086010) | 3.23573040 |
| 112 | sodium ion export (GO:0071436) | 3.20902197 |
| 113 | endocrine hormone secretion (GO:0060986) | 3.20531954 |
| 114 | striatum development (GO:0021756) | 3.18364068 |
| 115 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.17243067 |
| 116 | ATP synthesis coupled proton transport (GO:0015986) | 3.17243067 |
| 117 | long-term synaptic potentiation (GO:0060291) | 3.16872668 |
| 118 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.14659152 |
| 119 | regulation of amine transport (GO:0051952) | 3.13871458 |
| 120 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.13485318 |
| 121 | regulation of synapse structural plasticity (GO:0051823) | 3.13082458 |
| 122 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.12285187 |
| 123 | locomotory exploration behavior (GO:0035641) | 3.09965802 |
| 124 | nitric oxide biosynthetic process (GO:0006809) | 3.09600869 |
| 125 | regulation of cell communication by electrical coupling (GO:0010649) | 3.09334312 |
| 126 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.08982824 |
| 127 | dopamine receptor signaling pathway (GO:0007212) | 3.08524222 |
| 128 | potassium ion transport (GO:0006813) | 3.08453166 |
| 129 | cellular response to ammonium ion (GO:0071242) | 3.08132078 |
| 130 | adult walking behavior (GO:0007628) | 3.07559135 |
| 131 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.05088452 |
| 132 | regulation of neurotransmitter transport (GO:0051588) | 3.04610462 |
| 133 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.03122698 |
| 134 | L-glutamate transport (GO:0015813) | 3.03016124 |
| 135 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.02326001 |
| 136 | synaptic transmission (GO:0007268) | 3.02239275 |
| 137 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.01927226 |
| 138 | neurotransmitter transport (GO:0006836) | 3.00322979 |
| 139 | response to cocaine (GO:0042220) | 3.00204827 |
| 140 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.99931829 |
| 141 | regulation of postsynaptic membrane potential (GO:0060078) | 2.99723472 |
| 142 | primary amino compound metabolic process (GO:1901160) | 2.99110682 |
| 143 | filopodium assembly (GO:0046847) | 2.98834747 |
| 144 | cell communication by electrical coupling (GO:0010644) | 2.98165390 |
| 145 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.97007900 |
| 146 | response to histamine (GO:0034776) | 2.95930753 |
| 147 | neuronal action potential (GO:0019228) | 2.95656559 |
| 148 | membrane hyperpolarization (GO:0060081) | 2.94666315 |
| 149 | long-term memory (GO:0007616) | 2.94649813 |
| 150 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.93602122 |
| 151 | regulation of vesicle fusion (GO:0031338) | 2.92416676 |
| 152 | synapse assembly (GO:0007416) | 2.91563596 |
| 153 | protein polyglutamylation (GO:0018095) | 2.91462902 |
| 154 | cellular copper ion homeostasis (GO:0006878) | 2.91035736 |
| 155 | positive regulation of membrane potential (GO:0045838) | 2.90855522 |
| 156 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.89034012 |
| 157 | rhodopsin mediated signaling pathway (GO:0016056) | 2.87986057 |
| 158 | respiratory electron transport chain (GO:0022904) | 2.87849198 |
| 159 | neuromuscular process controlling posture (GO:0050884) | 2.86472387 |
| 160 | electron transport chain (GO:0022900) | 2.85054663 |
| 161 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.84460567 |
| 162 | activation of protein kinase A activity (GO:0034199) | 2.84451762 |
| 163 | prepulse inhibition (GO:0060134) | 2.84319717 |
| 164 | chemosensory behavior (GO:0007635) | 2.84076465 |
| 165 | membrane depolarization (GO:0051899) | 2.82338284 |
| 166 | short-term memory (GO:0007614) | 10.8588266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.42222737 |
| 2 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 5.23470554 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.71633343 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.90246886 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.82657397 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.80174644 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.70617488 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69782486 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69782486 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.64874126 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.54182236 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.50250233 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.46123678 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.44943603 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.44632132 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.40978357 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.40290740 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.36381759 |
| 19 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.34658170 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.30938790 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21662314 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.19775816 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.16799628 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13753870 |
| 25 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.11357087 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.09786435 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.03265149 |
| 28 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.91105083 |
| 29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.89183414 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.87453589 |
| 31 | VDR_22108803_ChIP-Seq_LS180_Human | 1.83869623 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.82117026 |
| 33 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.79088034 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.76867203 |
| 35 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74271181 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.71855326 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.67053818 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.61014028 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57985588 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.47265590 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47117387 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44341855 |
| 43 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.44086166 |
| 44 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.43369890 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.41359981 |
| 46 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38742106 |
| 47 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.38200391 |
| 48 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.37879991 |
| 49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.37380600 |
| 50 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.35814365 |
| 51 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.34808603 |
| 52 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.34234130 |
| 53 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.33949910 |
| 54 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.28336133 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27453180 |
| 56 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.25517724 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23627834 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22591392 |
| 59 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20681974 |
| 60 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17708812 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16709892 |
| 62 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.16280156 |
| 63 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16280156 |
| 64 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15773510 |
| 65 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15578427 |
| 66 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14596047 |
| 67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13923951 |
| 68 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11580768 |
| 69 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08160296 |
| 70 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.08008531 |
| 71 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.07262534 |
| 72 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06774492 |
| 73 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.06098419 |
| 74 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05310931 |
| 75 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.04450799 |
| 76 | AR_19668381_ChIP-Seq_PC3_Human | 1.03163834 |
| 77 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02792263 |
| 78 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01655836 |
| 79 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01602388 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01394960 |
| 81 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00996347 |
| 82 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.00127215 |
| 83 | JUN_21703547_ChIP-Seq_K562_Human | 0.99895136 |
| 84 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99419357 |
| 85 | STAT3_23295773_ChIP-Seq_U87_Human | 0.98705035 |
| 86 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98479565 |
| 87 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.97748186 |
| 88 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97031268 |
| 89 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.96873551 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96474450 |
| 91 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96330465 |
| 92 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96310610 |
| 93 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.95874489 |
| 94 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95553807 |
| 95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94969191 |
| 96 | FUS_26573619_Chip-Seq_HEK293_Human | 0.94734209 |
| 97 | EWS_26573619_Chip-Seq_HEK293_Human | 0.93844247 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92849876 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92624178 |
| 100 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92379257 |
| 101 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.91551121 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91212223 |
| 103 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91128865 |
| 104 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.91067628 |
| 105 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90828462 |
| 106 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90464979 |
| 107 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.90312362 |
| 108 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.89977200 |
| 109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89232311 |
| 110 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89185581 |
| 111 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.87955394 |
| 112 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87864936 |
| 113 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.87666839 |
| 114 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87297948 |
| 115 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.87172283 |
| 116 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.86982836 |
| 117 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.86967478 |
| 118 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86871665 |
| 119 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84267244 |
| 120 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.84230298 |
| 121 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.84069229 |
| 122 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.82267372 |
| 123 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.81328560 |
| 124 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.81122387 |
| 125 | * CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.80388070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001984_abnormal_olfaction | 8.78903195 |
| 2 | MP0003880_abnormal_central_pattern | 4.02839225 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.61683003 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.30463105 |
| 5 | MP0009046_muscle_twitch | 3.23316275 |
| 6 | MP0005394_taste/olfaction_phenotype | 3.09405016 |
| 7 | MP0005499_abnormal_olfactory_system | 3.09405016 |
| 8 | MP0008789_abnormal_olfactory_epithelium | 2.98049277 |
| 9 | MP0002272_abnormal_nervous_system | 2.77977593 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.55626019 |
| 11 | MP0009745_abnormal_behavioral_response | 2.54717988 |
| 12 | MP0002064_seizures | 2.54665269 |
| 13 | MP0002184_abnormal_innervation | 2.54378961 |
| 14 | MP0002063_abnormal_learning/memory/cond | 2.49946578 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.41075342 |
| 16 | MP0001486_abnormal_startle_reflex | 2.31988173 |
| 17 | MP0005551_abnormal_eye_electrophysiolog | 2.29562212 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.24260135 |
| 19 | MP0004270_analgesia | 2.22081666 |
| 20 | MP0001968_abnormal_touch/_nociception | 2.20597644 |
| 21 | MP0005645_abnormal_hypothalamus_physiol | 2.14026284 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.06496416 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.00667640 |
| 24 | MP0002557_abnormal_social/conspecific_i | 1.96472620 |
| 25 | MP0001501_abnormal_sleep_pattern | 1.92765767 |
| 26 | MP0001188_hyperpigmentation | 1.92018198 |
| 27 | MP0001440_abnormal_grooming_behavior | 1.87202204 |
| 28 | MP0008569_lethality_at_weaning | 1.82419359 |
| 29 | MP0002736_abnormal_nociception_after | 1.78927490 |
| 30 | MP0001485_abnormal_pinna_reflex | 1.73639254 |
| 31 | MP0003878_abnormal_ear_physiology | 1.72476871 |
| 32 | MP0005377_hearing/vestibular/ear_phenot | 1.72476871 |
| 33 | MP0004742_abnormal_vestibular_system | 1.69644608 |
| 34 | MP0004036_abnormal_muscle_relaxation | 1.59661125 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.53279310 |
| 36 | MP0002882_abnormal_neuron_morphology | 1.51817802 |
| 37 | MP0001970_abnormal_pain_threshold | 1.50999789 |
| 38 | MP0000778_abnormal_nervous_system | 1.48828109 |
| 39 | MP0003879_abnormal_hair_cell | 1.44951127 |
| 40 | MP0002822_catalepsy | 1.41841787 |
| 41 | MP0002752_abnormal_somatic_nervous | 1.40534046 |
| 42 | MP0002160_abnormal_reproductive_system | 1.39903110 |
| 43 | MP0002735_abnormal_chemical_nociception | 1.38202523 |
| 44 | MP0004145_abnormal_muscle_electrophysio | 1.37860758 |
| 45 | MP0004142_abnormal_muscle_tone | 1.37650036 |
| 46 | MP0003011_delayed_dark_adaptation | 1.37498267 |
| 47 | MP0000566_synostosis | 1.37359073 |
| 48 | MP0010386_abnormal_urinary_bladder | 1.32670948 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.30508678 |
| 50 | MP0004924_abnormal_behavior | 1.30494124 |
| 51 | MP0005386_behavior/neurological_phenoty | 1.30494124 |
| 52 | MP0004858_abnormal_nervous_system | 1.29971956 |
| 53 | MP0002229_neurodegeneration | 1.27193338 |
| 54 | MP0001502_abnormal_circadian_rhythm | 1.25865962 |
| 55 | MP0000358_abnormal_cell_content/ | 1.21048093 |
| 56 | MP0001529_abnormal_vocalization | 1.20973492 |
| 57 | MP0004084_abnormal_cardiac_muscle | 1.20836805 |
| 58 | MP0006072_abnormal_retinal_apoptosis | 1.17271547 |
| 59 | MP0002066_abnormal_motor_capabilities/c | 1.17117512 |
| 60 | MP0004811_abnormal_neuron_physiology | 1.17086650 |
| 61 | MP0002152_abnormal_brain_morphology | 1.14434951 |
| 62 | MP0002733_abnormal_thermal_nociception | 1.13371954 |
| 63 | MP0005620_abnormal_muscle_contractility | 1.11003716 |
| 64 | MP0001963_abnormal_hearing_physiology | 1.07866837 |
| 65 | MP0004043_abnormal_pH_regulation | 1.07484741 |
| 66 | MP0003123_paternal_imprinting | 1.03910979 |
| 67 | MP0003329_amyloid_beta_deposits | 1.03747792 |
| 68 | MP0001986_abnormal_taste_sensitivity | 1.03171657 |
| 69 | MP0001905_abnormal_dopamine_level | 1.00882362 |
| 70 | MP0003122_maternal_imprinting | 1.00168766 |
| 71 | MP0000920_abnormal_myelination | 0.99588176 |
| 72 | MP0000955_abnormal_spinal_cord | 0.98890025 |
| 73 | MP0002090_abnormal_vision | 0.98295167 |
| 74 | MP0004215_abnormal_myocardial_fiber | 0.97000459 |
| 75 | MP0002909_abnormal_adrenal_gland | 0.95806999 |
| 76 | MP0000372_irregular_coat_pigmentation | 0.95735068 |
| 77 | MP0006035_abnormal_mitochondrial_morpho | 0.91431148 |
| 78 | MP0000013_abnormal_adipose_tissue | 0.88541662 |
| 79 | MP0000631_abnormal_neuroendocrine_gland | 0.88439767 |
| 80 | MP0009379_abnormal_foot_pigmentation | 0.88259827 |
| 81 | MP0000569_abnormal_digit_pigmentation | 0.87840715 |
| 82 | MP0004885_abnormal_endolymph | 0.86509218 |
| 83 | MP0000026_abnormal_inner_ear | 0.86076246 |
| 84 | MP0002653_abnormal_ependyma_morphology | 0.83495313 |
| 85 | MP0003631_nervous_system_phenotype | 0.82976379 |
| 86 | MP0003633_abnormal_nervous_system | 0.82923738 |
| 87 | MP0005195_abnormal_posterior_eye | 0.82832881 |
| 88 | MP0008877_abnormal_DNA_methylation | 0.82671150 |
| 89 | MP0005410_abnormal_fertilization | 0.82499965 |
| 90 | MP0002837_dystrophic_cardiac_calcinosis | 0.81719577 |
| 91 | MP0002277_abnormal_respiratory_mucosa | 0.81713089 |
| 92 | MP0009697_abnormal_copulation | 0.76466912 |
| 93 | MP0002638_abnormal_pupillary_reflex | 0.76136164 |
| 94 | MP0005253_abnormal_eye_physiology | 0.75225499 |
| 95 | MP0008872_abnormal_physiological_respon | 0.73914723 |
| 96 | MP0005171_absent_coat_pigmentation | 0.69911221 |
| 97 | MP0000538_abnormal_urinary_bladder | 0.69871161 |
| 98 | MP0001542_abnormal_bone_strength | 0.69665679 |
| 99 | MP0005187_abnormal_penis_morphology | 0.68788709 |
| 100 | MP0003868_abnormal_feces_composition | 0.66457240 |
| 101 | MP0004147_increased_porphyrin_level | 0.66410653 |
| 102 | MP0005389_reproductive_system_phenotype | 0.65719778 |
| 103 | MP0004233_abnormal_muscle_weight | 0.65311731 |
| 104 | MP0008874_decreased_physiological_sensi | 0.65155643 |
| 105 | MP0002069_abnormal_eating/drinking_beha | 0.64882979 |
| 106 | MP0005595_abnormal_vascular_smooth | 0.62851690 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.62569381 |
| 108 | MP0003861_abnormal_nervous_system | 0.61836126 |
| 109 | MP0003634_abnormal_glial_cell | 0.61720472 |
| 110 | MP0000534_abnormal_ureter_morphology | 0.59873455 |
| 111 | MP0002233_abnormal_nose_morphology | 0.58766168 |
| 112 | MP0003632_abnormal_nervous_system | 0.58485859 |
| 113 | MP0008775_abnormal_heart_ventricle | 0.56937624 |
| 114 | MP0001299_abnormal_eye_distance/ | 0.56914954 |
| 115 | MP0003787_abnormal_imprinting | 0.56052020 |
| 116 | MP0004085_abnormal_heartbeat | 0.55701891 |
| 117 | MP0001765_abnormal_ion_homeostasis | 0.55405943 |
| 118 | MP0004484_altered_response_of | 0.53712159 |
| 119 | MP0000749_muscle_degeneration | 0.53592057 |
| 120 | MP0006292_abnormal_olfactory_placode | 0.51227478 |
| 121 | MP0003137_abnormal_impulse_conducting | 0.50064851 |
| 122 | MP0000015_abnormal_ear_pigmentation | 0.48600239 |
| 123 | MP0005623_abnormal_meninges_morphology | 0.48409757 |
| 124 | MP0005535_abnormal_body_temperature | 0.47250547 |
| 125 | MP0000343_altered_response_to | 0.47218328 |
| 126 | MP0010770_preweaning_lethality | 0.46446998 |
| 127 | MP0000230_abnormal_systemic_arterial | 0.45808879 |
| 128 | MP0005174_abnormal_tail_pigmentation | 0.44965296 |
| 129 | MP0003956_abnormal_body_size | 0.44039756 |
| 130 | MP0010234_abnormal_vibrissa_follicle | 0.43607350 |
| 131 | MP0002083_premature_death | 0.42136007 |
| 132 | MP0002082_postnatal_lethality | 0.40953387 |
| 133 | MP0010769_abnormal_survival | 0.39170987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atonic seizures (HP:0010819) | 6.21756743 |
| 2 | Postural tremor (HP:0002174) | 5.98770345 |
| 3 | Febrile seizures (HP:0002373) | 5.91708050 |
| 4 | Focal motor seizures (HP:0011153) | 5.37599606 |
| 5 | Intention tremor (HP:0002080) | 5.23216742 |
| 6 | Absence seizures (HP:0002121) | 5.20086009 |
| 7 | Abnormality of macular pigmentation (HP:0008002) | 5.18909843 |
| 8 | Impaired vibration sensation in the lower limbs (HP:0002166) | 4.93317316 |
| 9 | Myokymia (HP:0002411) | 4.91769642 |
| 10 | Focal seizures (HP:0007359) | 4.59975762 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 4.52745142 |
| 12 | Visual hallucinations (HP:0002367) | 4.40615404 |
| 13 | Dialeptic seizures (HP:0011146) | 4.36270039 |
| 14 | Epileptic encephalopathy (HP:0200134) | 4.29251323 |
| 15 | Retinal dysplasia (HP:0007973) | 4.23052145 |
| 16 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.12013977 |
| 17 | Gait imbalance (HP:0002141) | 3.99435749 |
| 18 | Abnormality of saccadic eye movements (HP:0000570) | 3.96555143 |
| 19 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.88278595 |
| 20 | Congenital primary aphakia (HP:0007707) | 3.84907457 |
| 21 | Abnormality of ocular smooth pursuit (HP:0000617) | 3.84851790 |
| 22 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.78549767 |
| 23 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.78549767 |
| 24 | Medial flaring of the eyebrow (HP:0010747) | 3.67331782 |
| 25 | Abnormal ciliary motility (HP:0012262) | 3.60884151 |
| 26 | Nephrogenic diabetes insipidus (HP:0009806) | 3.56465742 |
| 27 | Generalized tonic-clonic seizures (HP:0002069) | 3.50446728 |
| 28 | Limb dystonia (HP:0002451) | 3.42397680 |
| 29 | Limb ataxia (HP:0002070) | 3.32788991 |
| 30 | Congenital stationary night blindness (HP:0007642) | 3.30120542 |
| 31 | Acute necrotizing encephalopathy (HP:0006965) | 3.26484023 |
| 32 | Rhinitis (HP:0012384) | 3.18077491 |
| 33 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.15511536 |
| 34 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.15511536 |
| 35 | Abnormality of midbrain morphology (HP:0002418) | 3.13866754 |
| 36 | Molar tooth sign on MRI (HP:0002419) | 3.13866754 |
| 37 | Abnormality of the corticospinal tract (HP:0002492) | 3.08675816 |
| 38 | Vaginal atresia (HP:0000148) | 3.04997944 |
| 39 | Dysdiadochokinesis (HP:0002075) | 3.04894535 |
| 40 | Progressive macrocephaly (HP:0004481) | 3.04081893 |
| 41 | Central scotoma (HP:0000603) | 3.01751937 |
| 42 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.00459641 |
| 43 | Genital tract atresia (HP:0001827) | 2.98588773 |
| 44 | Action tremor (HP:0002345) | 2.92592119 |
| 45 | Poor coordination (HP:0002370) | 2.88909686 |
| 46 | Impaired vibratory sensation (HP:0002495) | 2.87401775 |
| 47 | Gait ataxia (HP:0002066) | 2.87278247 |
| 48 | Gaze-evoked nystagmus (HP:0000640) | 2.83466139 |
| 49 | Truncal ataxia (HP:0002078) | 2.76730024 |
| 50 | Mitochondrial inheritance (HP:0001427) | 2.75483040 |
| 51 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.74355280 |
| 52 | Scanning speech (HP:0002168) | 2.68580466 |
| 53 | Broad-based gait (HP:0002136) | 2.65285427 |
| 54 | Bifid tongue (HP:0010297) | 2.60733810 |
| 55 | Acute encephalopathy (HP:0006846) | 2.56983169 |
| 56 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.53782834 |
| 57 | Syncope (HP:0001279) | 2.53682199 |
| 58 | Autoamputation (HP:0001218) | 2.49212998 |
| 59 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.46698993 |
| 60 | Optic disc pallor (HP:0000543) | 2.43234584 |
| 61 | Dysmetria (HP:0001310) | 2.41186354 |
| 62 | Hyperventilation (HP:0002883) | 2.39192731 |
| 63 | True hermaphroditism (HP:0010459) | 2.35832448 |
| 64 | Pancreatic fibrosis (HP:0100732) | 2.33596522 |
| 65 | Anosmia (HP:0000458) | 2.28562943 |
| 66 | Anxiety (HP:0000739) | 2.27605950 |
| 67 | Cerebellar atrophy (HP:0001272) | 2.24703613 |
| 68 | Hypothermia (HP:0002045) | 2.23359421 |
| 69 | Increased CSF lactate (HP:0002490) | 2.22915857 |
| 70 | Hemiparesis (HP:0001269) | 2.21634792 |
| 71 | Hyperlipoproteinemia (HP:0010980) | 2.20584200 |
| 72 | Dysphonia (HP:0001618) | 2.20349470 |
| 73 | Depression (HP:0000716) | 2.18924496 |
| 74 | Increased serum pyruvate (HP:0003542) | 2.18701134 |
| 75 | Postaxial hand polydactyly (HP:0001162) | 2.17387951 |
| 76 | Specific learning disability (HP:0001328) | 2.16131634 |
| 77 | Palpitations (HP:0001962) | 2.15965748 |
| 78 | Cerebral edema (HP:0002181) | 2.13870213 |
| 79 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.13542282 |
| 80 | Amblyopia (HP:0000646) | 2.12775304 |
| 81 | Ventricular fibrillation (HP:0001663) | 2.09911631 |
| 82 | Slow progression (HP:0003677) | 2.09818133 |
| 83 | Chronic bronchitis (HP:0004469) | 2.07544530 |
| 84 | Insidious onset (HP:0003587) | 2.07437189 |
| 85 | Termporal pattern (HP:0011008) | 2.07437189 |
| 86 | Focal dystonia (HP:0004373) | 2.05192305 |
| 87 | Retinitis pigmentosa (HP:0000510) | 2.04239896 |
| 88 | Torticollis (HP:0000473) | 2.03117013 |
| 89 | Severe visual impairment (HP:0001141) | 2.02139631 |
| 90 | Decreased central vision (HP:0007663) | 2.01882266 |
| 91 | Impaired smooth pursuit (HP:0007772) | 2.00104366 |
| 92 | Absent/shortened dynein arms (HP:0200106) | 1.99780891 |
| 93 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.99780891 |
| 94 | Athetosis (HP:0002305) | 1.96684708 |
| 95 | Nephronophthisis (HP:0000090) | 1.96667392 |
| 96 | Chronic hepatic failure (HP:0100626) | 1.94640925 |
| 97 | Abnormality of glycolysis (HP:0004366) | 1.94617911 |
| 98 | Degeneration of anterior horn cells (HP:0002398) | 1.94180759 |
| 99 | Abnormality of the anterior horn cell (HP:0006802) | 1.94180759 |
| 100 | Dysarthria (HP:0001260) | 1.94044101 |
| 101 | Lipid accumulation in hepatocytes (HP:0006561) | 1.94005202 |
| 102 | Hepatocellular necrosis (HP:0001404) | 1.93979970 |
| 103 | Abolished electroretinogram (ERG) (HP:0000550) | 1.92349029 |
| 104 | Diplopia (HP:0000651) | 1.90033128 |
| 105 | Abnormality of binocular vision (HP:0011514) | 1.90033128 |
| 106 | Epileptiform EEG discharges (HP:0011182) | 1.89518508 |
| 107 | Status epilepticus (HP:0002133) | 1.88977688 |
| 108 | Agitation (HP:0000713) | 1.88637884 |
| 109 | Renal Fanconi syndrome (HP:0001994) | 1.87343159 |
| 110 | Abnormal hair whorl (HP:0010721) | 1.86270434 |
| 111 | Prolonged QT interval (HP:0001657) | 1.86101177 |
| 112 | Horizontal nystagmus (HP:0000666) | 1.85536309 |
| 113 | Supranuclear gaze palsy (HP:0000605) | 1.85281281 |
| 114 | Scotoma (HP:0000575) | 1.84539672 |
| 115 | Dysmetric saccades (HP:0000641) | 1.84455122 |
| 116 | EEG with generalized epileptiform discharges (HP:0011198) | 1.83302022 |
| 117 | Sudden death (HP:0001699) | 1.80977121 |
| 118 | Pancreatic cysts (HP:0001737) | 1.79686892 |
| 119 | Genetic anticipation (HP:0003743) | 1.79227143 |
| 120 | Hemiplegia (HP:0002301) | 1.77754335 |
| 121 | Occipital encephalocele (HP:0002085) | 1.75986078 |
| 122 | Craniofacial dystonia (HP:0012179) | 1.74041905 |
| 123 | Leukodystrophy (HP:0002415) | 1.73035389 |
| 124 | Esotropia (HP:0000565) | 1.72053285 |
| 125 | Left ventricular hypertrophy (HP:0001712) | 1.71617892 |
| 126 | Synostosis involving the elbow (HP:0003938) | 1.70699705 |
| 127 | Humeroradial synostosis (HP:0003041) | 1.70699705 |
| 128 | Increased hepatocellular lipid droplets (HP:0006565) | 1.70430678 |
| 129 | Increased intramyocellular lipid droplets (HP:0012240) | 1.65652159 |
| 130 | Urinary urgency (HP:0000012) | 1.57567153 |
| 131 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.57089087 |
| 132 | Intellectual disability, mild (HP:0001256) | 1.51599718 |
| 133 | Heterochromia iridis (HP:0001100) | 1.50506475 |
| 134 | Choroideremia (HP:0001139) | 1.49244464 |
| 135 | Epidermoid cyst (HP:0200040) | 1.48611528 |
| 136 | Incomplete penetrance (HP:0003829) | 1.48203030 |
| 137 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.47154107 |
| 138 | Exercise intolerance (HP:0003546) | 1.46329481 |
| 139 | Aplasia involving bones of the extremities (HP:0009825) | 1.45892442 |
| 140 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.45892442 |
| 141 | Aplasia of the phalanges of the hand (HP:0009802) | 1.45892442 |
| 142 | X-linked dominant inheritance (HP:0001423) | 1.45458369 |
| 143 | Progressive inability to walk (HP:0002505) | 1.38815021 |
| 144 | Skin nodule (HP:0200036) | 1.38678854 |
| 145 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.36727913 |
| 146 | Respiratory failure (HP:0002878) | 1.35246542 |
| 147 | Increased muscle lipid content (HP:0009058) | 1.29102947 |
| 148 | Distal lower limb amyotrophy (HP:0008944) | 1.28814372 |
| 149 | Exertional dyspnea (HP:0002875) | 1.27256436 |
| 150 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.26126129 |
| 151 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.26126129 |
| 152 | Global brain atrophy (HP:0002283) | 1.25828700 |
| 153 | Spastic gait (HP:0002064) | 1.24862438 |
| 154 | Congenital onset (HP:0003577) | 1.21767607 |
| 155 | Lactic acidosis (HP:0003128) | 1.21066785 |
| 156 | Hypsarrhythmia (HP:0002521) | 1.16525980 |
| 157 | Inability to walk (HP:0002540) | 1.16164114 |
| 158 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.14711300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ARAF | 4.97293926 |
| 2 | RIPK1 | 3.19067824 |
| 3 | MYLK | 2.88147837 |
| 4 | TTK | 2.72186464 |
| 5 | MAP3K4 | 2.65826502 |
| 6 | MAP2K7 | 2.55583933 |
| 7 | PRPF4B | 2.53809113 |
| 8 | CASK | 2.53744369 |
| 9 | DAPK2 | 2.47971044 |
| 10 | PHKG1 | 2.44576563 |
| 11 | PHKG2 | 2.44576563 |
| 12 | MINK1 | 2.27707385 |
| 13 | CAMKK2 | 2.20500204 |
| 14 | BRAF | 2.18983763 |
| 15 | EPHA4 | 2.13976658 |
| 16 | NTRK3 | 2.13923288 |
| 17 | MAP3K12 | 2.01586092 |
| 18 | CSNK1G1 | 2.01261799 |
| 19 | GRK5 | 1.90660433 |
| 20 | PLK2 | 1.86528584 |
| 21 | PNCK | 1.85025329 |
| 22 | PTK6 | 1.84446543 |
| 23 | PAK4 | 1.76317479 |
| 24 | PRKG2 | 1.73691549 |
| 25 | MAP2K4 | 1.73270772 |
| 26 | PIM2 | 1.72200544 |
| 27 | BMPR2 | 1.63739896 |
| 28 | PRKCG | 1.60614095 |
| 29 | ERBB3 | 1.58374108 |
| 30 | TESK1 | 1.55923664 |
| 31 | NME1 | 1.54787919 |
| 32 | CAMK2B | 1.52730432 |
| 33 | MAP3K9 | 1.50339425 |
| 34 | RIPK4 | 1.50133053 |
| 35 | MARK1 | 1.49975605 |
| 36 | CAMK2D | 1.48355257 |
| 37 | DAPK1 | 1.47251970 |
| 38 | NTRK2 | 1.46748742 |
| 39 | PDK1 | 1.38602754 |
| 40 | MAPK15 | 1.38225910 |
| 41 | CAMK2G | 1.35894013 |
| 42 | STK38 | 1.35790494 |
| 43 | CDK19 | 1.23926173 |
| 44 | PAK3 | 1.23388968 |
| 45 | SIK2 | 1.20770891 |
| 46 | PAK6 | 1.18586591 |
| 47 | TNIK | 1.14750011 |
| 48 | RAF1 | 1.14306557 |
| 49 | DYRK1A | 1.10628062 |
| 50 | AKT3 | 1.08524807 |
| 51 | CAMK2A | 1.07647743 |
| 52 | LIMK1 | 1.07060009 |
| 53 | STK24 | 1.06545478 |
| 54 | ITK | 1.01971594 |
| 55 | CAMKK1 | 1.00989176 |
| 56 | FYN | 1.00630091 |
| 57 | CDK5 | 0.97332171 |
| 58 | STK38L | 0.96756418 |
| 59 | TAF1 | 0.89984910 |
| 60 | TLK1 | 0.88375464 |
| 61 | PINK1 | 0.86431344 |
| 62 | KSR1 | 0.84830436 |
| 63 | CAMK1G | 0.84066707 |
| 64 | MAPK13 | 0.81984542 |
| 65 | SCYL2 | 0.81464799 |
| 66 | WNK1 | 0.79070266 |
| 67 | CSNK1A1 | 0.78431909 |
| 68 | CDK3 | 0.76105933 |
| 69 | MAP3K6 | 0.75481723 |
| 70 | PRKCE | 0.74991083 |
| 71 | OXSR1 | 0.74117288 |
| 72 | FER | 0.70097876 |
| 73 | CAMK1 | 0.69690774 |
| 74 | SGK223 | 0.68726231 |
| 75 | SGK494 | 0.68726231 |
| 76 | CDK14 | 0.67473543 |
| 77 | MAP3K11 | 0.66810073 |
| 78 | STK11 | 0.66316539 |
| 79 | CDK18 | 0.63470638 |
| 80 | ROCK2 | 0.62560372 |
| 81 | TSSK6 | 0.61970693 |
| 82 | PRKDC | 0.61703538 |
| 83 | CDK15 | 0.60849087 |
| 84 | FGR | 0.60262756 |
| 85 | NEK1 | 0.59423210 |
| 86 | TAOK2 | 0.57712341 |
| 87 | DAPK3 | 0.56598889 |
| 88 | TRIM28 | 0.56401699 |
| 89 | CSNK1D | 0.56060220 |
| 90 | CSNK1G2 | 0.56053313 |
| 91 | MAP3K2 | 0.55109093 |
| 92 | PLK3 | 0.54764280 |
| 93 | SRC | 0.54208466 |
| 94 | PTK2B | 0.53949489 |
| 95 | FES | 0.53228320 |
| 96 | SGK2 | 0.53051666 |
| 97 | RPS6KA3 | 0.52995388 |
| 98 | PRKACA | 0.52476983 |
| 99 | CHEK2 | 0.51783556 |
| 100 | CAMK4 | 0.51639012 |
| 101 | TNK2 | 0.51178662 |
| 102 | PRKG1 | 0.50515966 |
| 103 | CDK11A | 0.50506718 |
| 104 | PTK2 | 0.50356271 |
| 105 | PRKCZ | 0.50021081 |
| 106 | UHMK1 | 0.48665193 |
| 107 | BCR | 0.46820633 |
| 108 | LATS2 | 0.46743147 |
| 109 | MOS | 0.45926850 |
| 110 | CSNK1A1L | 0.45848960 |
| 111 | EIF2AK1 | 0.45808588 |
| 112 | PRKCA | 0.44729315 |
| 113 | CSNK1E | 0.44619142 |
| 114 | TYRO3 | 0.43471190 |
| 115 | CCNB1 | 0.43018549 |
| 116 | RPS6KA2 | 0.42658507 |
| 117 | TEC | 0.42635128 |
| 118 | STK39 | 0.42458520 |
| 119 | CSNK1G3 | 0.42052574 |
| 120 | PRKCB | 0.41393777 |
| 121 | HIPK2 | 0.40835374 |
| 122 | GRK6 | 0.40761347 |
| 123 | MAP3K13 | 0.40532539 |
| 124 | KSR2 | 0.40074051 |
| 125 | MAPKAPK5 | 0.39798387 |
| 126 | RPS6KB1 | 0.38889186 |
| 127 | PRKCI | 0.37377327 |
| 128 | GRK7 | 0.35451882 |
| 129 | MAPK10 | 0.33263137 |
| 130 | STK16 | 0.33220344 |
| 131 | ADRBK1 | 0.31332238 |
| 132 | ILK | 0.30656203 |
| 133 | PRKACG | 0.30087304 |
| 134 | WNK4 | 0.26089089 |
| 135 | MAPK1 | 0.25717223 |
| 136 | SGK1 | 0.24437313 |
| 137 | MAP4K2 | 0.20865277 |
| 138 | MARK2 | 0.20850896 |
| 139 | SIK3 | 0.18320431 |
| 140 | MAP3K1 | 0.16450076 |
| 141 | INSR | 0.11809480 |
| 142 | MAPK8 | 0.10608881 |
| 143 | ROCK1 | 0.09750763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Olfactory transduction_Homo sapiens_hsa04740 | 5.64911844 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.40404002 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.74020395 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.28046033 |
| 5 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.95469711 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.90075735 |
| 7 | * GABAergic synapse_Homo sapiens_hsa04727 | 2.74433722 |
| 8 | * Morphine addiction_Homo sapiens_hsa05032 | 2.63638665 |
| 9 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.60785220 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.49492273 |
| 11 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.45782352 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.44197729 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 2.26448032 |
| 14 | * Taste transduction_Homo sapiens_hsa04742 | 2.22656348 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 2.04978416 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 2.04384814 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 2.04063661 |
| 18 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.01163173 |
| 19 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.00886821 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.97421820 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.90688829 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.82777733 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.80650225 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.78298734 |
| 25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.72626212 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.70244205 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.68487788 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.66405668 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.65832563 |
| 30 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.62607336 |
| 31 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.58326602 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.56027330 |
| 33 | Huntingtons disease_Homo sapiens_hsa05016 | 1.47757193 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.47366466 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.42626307 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.33129933 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.26133243 |
| 38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20581930 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17426803 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.16601566 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16137288 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14388914 |
| 43 | Gap junction_Homo sapiens_hsa04540 | 1.11397061 |
| 44 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.07538092 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05568189 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91629697 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90255289 |
| 48 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87775526 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.86005399 |
| 50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.82519075 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82311697 |
| 52 | Melanogenesis_Homo sapiens_hsa04916 | 0.80349720 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78364391 |
| 54 | Cocaine addiction_Homo sapiens_hsa05030 | 0.76897922 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76379875 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74607236 |
| 57 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.71356716 |
| 58 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70106798 |
| 59 | * Alcoholism_Homo sapiens_hsa05034 | 0.67645550 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67584716 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62954464 |
| 62 | Protein export_Homo sapiens_hsa03060 | 0.62021714 |
| 63 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58028486 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.54276597 |
| 65 | Glioma_Homo sapiens_hsa05214 | 0.51750513 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50962996 |
| 67 | Axon guidance_Homo sapiens_hsa04360 | 0.49591576 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49225377 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49180435 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48535486 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47873384 |
| 72 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47573188 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46400107 |
| 74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.46207800 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45834192 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41745813 |
| 77 | Bile secretion_Homo sapiens_hsa04976 | 0.39180971 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38763661 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.38607668 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38125394 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38025758 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36398142 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34952017 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33349318 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33083750 |
| 86 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.32820818 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31851971 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.31534329 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30941865 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30242633 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27591897 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25752207 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.23524410 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.23325745 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.22878395 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22201242 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.22086102 |
| 98 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.21662224 |
| 99 | Tight junction_Homo sapiens_hsa04530 | 0.21608302 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20610712 |
| 101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.16815864 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.16265273 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.15888536 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.15470970 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.15453189 |
| 106 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.14630288 |
| 107 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.14345732 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.13877180 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.13675103 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.13327878 |
| 111 | Purine metabolism_Homo sapiens_hsa00230 | 0.13144993 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12744560 |
| 113 | Melanoma_Homo sapiens_hsa05218 | 0.10919136 |
| 114 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.09929129 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.09567499 |
| 116 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.09129136 |
| 117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.08841703 |
| 118 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.07740755 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.05618523 |
| 120 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.03993730 |
| 121 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.03924093 |
| 122 | Platelet activation_Homo sapiens_hsa04611 | 0.01840533 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.01808464 |
| 124 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.00252043 |
| 125 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0246397 |
| 126 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.0005592 |

